5Wainwright D, Madden M, Luterman A, et al. Clinical evaluation of an acellular allograft dermal matrix in full thickness burns. J burn Care Rehabil, 1996,18:147 - 155.
6Daniel A, sabine A, Maura E, et al. Differences in dermal analogs influence subsequent pigmentation, epidermal differentiation, basemet membrane, and rete ridge formation of transplanted composite skin grafts. Transplantation (Baltimore) , 1997,64:454 - 465.
7Wain Wright DJ.Use of an acellular allograft dermal matrix (Allo-Derm)in management of full-thickness[J].Burns,1995,21(4):243-248.
8Mckay L,Woodward B,Wood K,et al.Reconstraction of human skin from glycerol preserved allodermis and cultured kerationeyte sheets.Burns,1994,20(1):19.
9Sheridan RL,Morgan JR,Cusick JL,et al.Initial experienge with a composite autologous skin substitute.Burns 2001;27:421-424.
6Franz S, Rammelt S, Seharnweber D, et al. Immune respons- es to implants--A review of the implications for the design ofimmunomodulatory biomaterials [J]. Biomaterials,2011,32 (28) : 6692-6709.
7Man XY,Yang YH,Cai SQ,et al. Immunoloealization and expression of vascular endothelial growth factor reeeptors (VEGFRs)and neuropilins(NRPs)on kelatinoeytes in hu- man epidermis [J]. Mol Med, 2006,12(8) : 127-136.
8Chen RN, Ho HO, Tsai YT, et al. Process development of an acellular dermal matrix(ADM)for biomedical applica- tions [J]. Biomaterials, 2004,25 (10) :2679-2686.
